Changes in prescribing patterns and access to immune checkpoint inhibitors in german lung cancer patients – a claims data analysis

Changes in prescribing patterns and access to immune checkpoint inhibitors in german lung cancer patients – a claims data analysis

Abstract Background Recently, immune checkpoint inhibitors (ICIs) have driven profound changes in the treatment of non-small cell lung cancer (NSCLC). Their rapid integration into clinical routine is crucial for patient outcomes. However, prescribing patterns may not change immediately after authori...

Full description

Saved in:
Bibliographic Details
Main Authors: Julia Walter, Blerina Resuli, Laura Sellmer, Diego Kauffmann-Guerrero, Toki Bolt, Chukwuka Eze, Jürgen Behr, Amanda Tufman
Format: Article
Language:English
Published: BMC 2025-07-01
Series:BMC Public Health
Subjects:
NSCLC
Secondary data
Immunotherapy
Regional differences
Viral infections
Innovation.
Online Access:https://doi.org/10.1186/s12889-025-23846-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12889-025-23846-2

Similar Items